APLM
Apollomics Inc.
NASDAQ · Healthcare · Biotechnology · US
$23.42
+3.97%Leverage
- Debt / equity
- -0.20x
- Net debt / equity
- 0.83x
- Debt / assets
- 0.10x
- Debt / EBITDA
- -0.07x
- Net debt / EBITDA
- 0.28x
Liquidity & coverage
- Current ratio
- 0.96x
- Quick ratio
- 0.96x
- Cash ratio
- 0.52x
- Interest coverage
- -145.74x
- EBITDA / interest
- -145.74x
- Working capital
- -$275.0K
Cash & dividend
- FCF / debt
- -16.13x
- Cash flow / debt
- -16.13x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025